Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 19 May, 2015
+/- Eval for secondary causes/conditions that may influence statin safety
By
vgreene
, 19 May, 2015
Eval/treat TG ≥500 mg/dL, unexplained ALT >3x ULN
By
vgreene
, 19 May, 2015
Fasting lipid panel, ALT, CK (if indicated)
By
vgreene
, 19 May, 2015
Mod-intensity statin<sup>14</sup> + lifestyle
By
vgreene
, 19 May, 2015
fluvastatin 40 mg bid
By
vgreene
, 19 May, 2015
lovastatin 40 mg daily
By
vgreene
, 19 May, 2015
pravastatin 40 mg daily
By
vgreene
, 19 May, 2015
simvastatin 20-40 mg daily
By
vgreene
, 19 May, 2015
rosuvastatin 10 mg daily
By
vgreene
, 19 May, 2015
atorvastatin 10 mg daily
Pagination
First page
Previous page
…
Page
3787
Page
3788
Page
3789
Page
3790
Current page
3791
Page
3792
Page
3793
Page
3794
Page
3795
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
